UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
[X ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2011
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ______ to ________
Commission File Number: 001-34274
LIFE NUTRITION PRODUCTS, INC.
(Exact name of registrant as specified in its charter)
Delaware | 42-1743717 | |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification Number) | |
c/o 30A Vreeland Road, Suite 230 Florham Park, New Jersey |
||
07932 | ||
(Address of principal executive offices) | (Zip Code) |
(973) 443-0600
(Registrant's Telephone Number, Including Area Code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
(X)Yes ( ) No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
( ) Yes ( ) No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer,""accelerated filer"and "smaller reporting company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer () Accelerated filer ()Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
(X) Yes ( ) No
As of May 20, 2011 there were 4,095,000 shares of common stock outstanding with a par value of $0.0001.
Table of Contents | ||
Page: | ||
Part I. | FINANCIAL INFORMATION | |
Item 1. Financial Statements (unaudited) | 3 | |
Condensed Consolidated Balance Sheets | 3 | |
Condensed Statements of Consolidated Operations | 4 | |
Condensed Statements of Consolidated Cash Flows | 5 | |
Notes to Condensed Consolidated Financial Statements | 6-10 | |
Item 2. Managements Discussion and Analysis of Financial Condition | 11-15 | |
and Results of Operations | ||
Item 3. Quantitative and Qualitative Disclosures about Market Risk | 14 | |
Item 4. Controls and Procedures | 14-15 | |
Part II. | OTHER INFORMATION | |
Item 1. Legal Proceedings | 15 | |
Item 1A. Risk Factors | 15 | |
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds | 15 | |
Item 3. Defaults Upon Senior Securities | 15 | |
Item 4. [Removed and Reserved] | 15 | |
Item 5. Other Information | 15 | |
Item 6. Exhibits | 15 | |
Signatures | 16 |
Life Nutrition Products, Inc. | ||||
Condensed Balance Sheets | ||||
As of March 31, 2011 (unaudited) and December 31, 2010 | ||||
March 31, | December 31, | |||
2011 | 2010 | |||
Assets | ||||
Current Assets | ||||
Cash | $ 499 | $ 68 | ||
Total Current Assets | 499 | 68 | ||
Property and Equipment, net | 592 | 900 | ||
Total Assets | $ 1,091 | $ 968 | ||
Liabilities and Stockholders' Deficit | ||||
Current Liabilities | ||||
Accounts payable and accrued expenses | $ 6,527 | $ 2,839 | ||
Note Payable | 55,000 | 55,000 | ||
Advances from Conqueror | 18,749 | - | ||
Loans payable | 16,768 | 16,768 | ||
Total Current Liabilities | 97,044 | 74,607 | ||
Total Liabilities | 97,044 | 74,607 | ||
Stockholders' Deficit | ||||
Preferred stock, $0.0001 par value, 2,000,000 authorized, | ||||
none issued and outstanding | - | - | ||
Common stock $0.0001 par value, 50,000,000 authorized, | 1,688 | 1,688 | ||
16,877,900 and 16,877,900 issued and outstanding as of | ||||
March 31, 2011 and December 31, 2010, respectively | ||||
Additional paid-in-capital | 460,533 | 460,533 | ||
Accumulated deficit | (558,174) | (535,860) | ||
Total Stockholders' Deficit | (95,953) | (73,639) | ||
Total Liabilities and Stockholders' Deficit | $ 1,091 | $ 968 |
The accompanying footnotes are an integral part of the condensed financial statements.
3
Life Nutrition Products, Inc.
Condensed Statements of Operations (unaudited)
For the Three Months Ended | |||
March 31, | |||
2011 | 2010 | ||
Revenues | $ - | $ 118 | |
Cost of Revenues | - | 70 | |
Gross Profit | - | 48 | |
Selling, General and Administrative | 21,626 | 9,732 | |
Loss from Operations | (21,626) | (9,684) | |
Interest expense | 688 | - | |
Net Loss attributable to common shareholders | $ (22,314) | $ (9,684) | |
Weighted Average Shares of Common Stock Outstanding- | |||
Basic and Diluted | 17,689,867 | 17,582,800 | |
Net Loss per Basic and Diluted Common Share | $ (0.00) | $ (0.00) |
The accompanying footnotes are an integral part of the condensed financial statements.
4
Life Nutrition Products, Inc. | |||
Condensed Statements of Cash Flows (unaudited) | |||
For the Three Months Ended | |||
March 31, | |||
2011 | 2010 | ||
Cash Flows from Operating Activities: | |||
Net Loss | $ (22,314) | $ (9,684) | |
Adjustments to reconcile net loss to net cash used in operating activities | |||
Depreciation | 308 | 308 | |
Changes in Assets and Liabilities | |||
Decrease in Inventory | - | 70 | |
Decrease in Prepaid Rent | - | 1,500 | |
Increase in Accounts Payable and Accrued Expenses | 3,688 | 6,500 | |
Net cash used in operating activities | (18,318) | (1,306) | |
Cash Flows from Financing Activities: | |||
Advances from Conqueror | 18,749 | - | |
Net cash provided by operating activities | 18,749 | - | |
Net decrease in cash | 431 | (1,306) | |
Cash at beginning of period | 68 | 4,461 | |
Cash at end of period | $ 499 | $ 3,155 | |
SUPPLEMENTARY DISCLOSURES OF CASH FLOW INFORMATION | |||
Cash paid during the year for: | |||
Interest | $ - | $ - | |
Income taxes | $ - | $ - | |
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING | |||
AND FINANCING ACTIVITIES: | |||
Stock issued to settle liability | $ - | $ 18,000 |
The accompanying footnotes are an integral part of the condensed financial statements.
5
Life Nutrition Products, Inc.
Notes to the Condensed Financial Statements (unaudited)
1. NATURE OF OPERATIONS AND BASIS OF PRESENTATION
The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States for the interim financial information and with the instructions to Form 10-Q and Regulation S-K as promulgated by the Securities and Exchange Commission. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, all normal recurring adjustments considered necessary for a fair statement of the results of operations have been included. The results of operations for the three months ended March 31, 2011 are not necessarily indicative of the results of operations for the full year. When reading the financial information contained in this Quarterly Report, reference should be made to the financial statements, schedule, and notes contained in the Company's annual report for the year ended, December 31, 2010.
Our previous primary business purpose was to market over-the-counter, all-natural dietary supplements under the trade names: Trim For Life3 Appetite Control and Trim For Life3 Energy Formula. The Trim For Life3 Appetite Control Formula is patent pending and supported by scientific studies. The Trim For Life3 Energy Formula is a proprietary formula blend. The Company is no longer pursuing this business.
Going Concern
The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplates continuation of the Company as a going concern. The Company has suffered recurring losses and experiences a deficiency of cash flow from operations. These matters raise substantial doubt about the Company's ability to continue as a going concern. The continued operations of the Company are dependent upon the Company's ability to raise capital and/or generate positive cash flows from operations. Management may achieve profitability and generate positive cash flows through possible acquisition or merger. However, there is no guarantee that a suitable offer may exist or that funding will be available to close on such a transaction. These financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classification of liabilities that might be necessary in the event the Company cannot continue in existence.
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America ("GAAP") requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from these estimates.
6
Life Nutrition Products, Inc.
Notes to the Condensed Financial Statements (unaudited)
(Continued)
Cash and Cash Equivalents
For purposes of the cash flow statements, the Company considers investments with an initial maturity of 3 months or less to be cash equivalents.
The Company maintains cash balances at financial institutions and are insured by the Federal Deposit Insurance Corporation up to federally insured limits. At times during the year, balances in certain bank accounts may exceed the FDIC insured limits.
Property and Equipment
Property and equipment are stated at cost. Depreciation and amortization are computed on the straight-line method based on the estimated useful lives of the assets. Repairs and maintenance charges, which do not increase the useful lives of the assets, are charged to operations as incurred.
Revenue Recognition
The Company recognizes revenue upon shipment of goods, and the price is fixed and determinable, and collectability is reasonably assured.
Net (Loss) Per Share of Common Stock
Historical net loss per common share is computed using the weighted average number of common shares outstanding. Diluted earnings per share (EPS) include additional dilution from common stock equivalents, such as stock issuable pursuant to the exercise of stock options and warrants. Common stock equivalents are not included in the computation of diluted earnings per share as the result is anti-dilutive for the periods presented.
Recent Accounting Pronouncements
As noted in our annual report on Form 10-K for the year ended December 31, 2010 filed April 2011, recent accounting pronouncements issued by the Financial Accounting Standards Board are not believed by the Company to have a significant material impact on the financial statements.
Income Taxes
The Company utilizes ASC 740, "Income Taxes," which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each period end based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.
ASC 740-10 prescribes detailed guidance for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in an enterprise's financial statements in accordance with generally accepted accounting standards. Tax positions must meet a more-likely-than-not recognition threshold at the effective date to be recognized.
7
Life Nutrition Products, Inc.
Notes to the Condensed Financial Statements (unaudited)
(Continued)
The tax effect of temporary differences, primarily net operating loss carryforwards, gave rise to the Company's deferred tax asset in the accompanying March 31, 2011 and December 31, 2010 balance sheets. Because of the current uncertainty of realizing the benefit of the tax carry forward, a valuation allowance equal to the tax benefit for deferred taxes has been established. The full realization of the tax benefit associated with the carry forward depends predominantly upon the Company's ability to generate taxable income during the carry forward period.
As of March 31, 2011 and December 31, 2010, the Company has net operating loss carry forwards of approximately $250,000 and $536,000 that can be utilized to offset future taxable income for Federal income tax purposes through 2029. Utilization of these net loss carry forwards is subject to the limitations of Internal Revenue Code Section 382. Significant components of the Company's deferred tax assets and liabilities are summarized as follows:
March 31, 2011 | December 31, 2010 | ||
Deferred tax asset | $ 100,000 | $ 186,000 | |
Less: Valuation allowance | 100,000 | (186,000) | |
Net Deferred Tax Asset | $ - | $ - |
Fair Value Measurements
The carrying amounts of the Company's financial instruments including cash, prepaid expenses, accrued expenses and officer loans, approximate fair value because of their short-term nature.
The Company follows ASC 820, which defines fair value, provides a consistent framework for measuring fair value under Generally Accepted Accounting Principles and expands fair value financial statement disclosure requirements. ASC 820's valuation techniques are based on observable and unobservable inputs. Observable inputs reflect readily obtainable data from independent sources, while unobservable inputs reflect our market assumptions. ASC 820 classifies these inputs into the following hierarchy:
Level 1 Inputs- Quoted prices for identical instruments in active markets.
Level 2 Inputs- Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.
Level 3 Inputs- Instruments with primarily unobservable value drivers.
8
Life Nutrition Products, Inc.
Condensed Notes to the Financial Statements (unaudited)
(Continued)
3. PROPERTY AND EQUIPMENT
At March 31, 2011 and December 31, 2010, property and equipment consists of the following:
March 31, | December 31, | Estimated | |||
2011 | 2010 | Useful Lives | |||
Computer Equipment | $ 4,324 | $ 4,324 | 3 years | ||
Website Development | 4,315 | 4,315 | 3 years | ||
Less: accumulated depreciation and amortization | (8,047) | (7,739) | |||
$ 1,091 | $ 900 | ||||
Note payable to Conqueror Group Limited in the amount of $55,000 bears 5% interest and is due on May 17, 2011. The Company has accrued and expensed $1,027 for interest as of March 31, 2011.
5. LOANS PAYABLE
The Company was advanced $5,598 from its former CEO in 2009, which is due on demand without interest. The Company was advanced $11,170 from a company controlled by the Company's former CEO in 2010. Total advances of $16,768 are due on demand without interest.
6. ADVANCES FROM CONQUEROR
During the three months ended March 31, 2011, the Company was advanced $18,749 from Conqueror (see Note 8), which is due on demand and carries a 5% interest rate.
7. STOCKHOLDERS' DEFICIT
We have authorized 2,000,000 shares of blank check preferred stock, none of which are issued and outstanding.
We have authorized 50,000,000 shares of common stock, par value $.0001 per share. As of March 31, 2011 there are 16,877,900 issued and outstanding. Subsequent to March 31, 2011, and in connection with the share exchange agreement (see note 8), the Company redeemed and cancelled 12,782,900 shares of its common stock.
8. SUBSEQUENT EVENTS
On September 7, 2010, the Registrant (the "Company") entered into a Share Exchange Agreement (the "Agreement") with Conqueror Group Limited, a Hong Kong corporation ("Conqueror") and Acumen Charm Ltd., a British Virgin Islands corporation (the "Conqueror Shareholder"). Pursuant to the Agreement, at the closing of the transaction contemplated in the Agreement (the "Transaction"), the Company will acquire 100% of the issued and outstanding capital stock of Conqueror from the Conqueror Shareholder, making Conqueror a wholly-owned subsidiary of the Company.
On November 17, 2010, the First Amendment to the Share Exchange Agreement (the "First Amendment") was entered into by the Registrant with Conqueror Group Limited, and Acumen Charm Ltd. The First Amendment Agreement provides that in the event that the closing does not occur for any reason on or before January 31, 2011, then, among other things, the Remaining Escrow Funds shall be paid to the Company and used to promptly redeem 12,782,900 shares as provided therein at the Group C Redemption Price, and the then officers and directors of the Company shall resign with immediate effect and appoint such persons as designated by Conqueror as officers and directors.
9
Life Nutrition Products, Inc.
Condensed Notes to the Financial Statements (unaudited)
(Continued)
The Closing was to transpire on or before January 31, 2011 but, as of the date hereof, has not occurred. As a result, on May 11, 2011, and in accordance with the terms of the First Amendment, the Remaining Escrow Funds were paid to the Company and were used to redeem 12,782,900 shares at the Group C Redemption Price and the Company delivered a promissory note to Conqueror in the principal amount of $49,731. On May 11, 2011, Michael M. Salerno, the Company's sole officer and director, resigned as an officer and director of the Company, and appointed Chu Zhanjun and Li Gang as directors, and Chu Zhanjun as President, Chief Executive Officer and Principal Financial Officer of the Company, each a designee of Conqueror.
On May 11, 2011, the Company's former CEO agreed to forgive and discharge all amounts due and owing to him for funds advanced or loans made to the Company (see Note 5).
10
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.
FORWARD LOOKING STATEMENT
This quarterly filing ending March 31, 2011 contains forward-looking statements that involve substantial risks and uncertainties. You can identify these statements by forward-looking words such as "may,""expect,""plans,""intends,""anticipate,""believe,""estimate"and "continue" or similar words and are intended to identify forward looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934. You should read statements that contain these words carefully because they discuss our future expectations or may contain projections of our future results of operations or of our financial condition or state other "forward-looking"information. We believe that it is important to communicate our future expectations to our investors. However, there may be events in the future that the Company is not able to accurately predict or control. Before you invest in the Company's common stock, you should be aware that the occurrence of the events described as risk factors and elsewhere in this annual filing could have a material adverse effect on our business, operating results and financial condition.
APPLICATION OF CRITICAL ACCOUNTING PRACTICES
This Management's Discussion and Analysis of Financial Condition and Results of Operations in this Quarterly Report ending March 31, 2011 on Form 10-Q should be read in conjunction with the accompanying Financial Statements and related notes. Our discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. ("GAAP").
Our significant accounting policies are more fully described in Notes to the financial statements. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and the related disclosures of contingent assets and liabilities. Actual results could differ from those estimates under different assumptions or conditions.
We review our estimates and assumptions on an on-going basis. Our estimates are based on our historical experience and other assumptions that we believe to be reasonable under the circumstances. Actual results are likely to differ from those estimates under different assumptions or conditions, but we do not believe such differences will materially affect our financial position or results of operations.
OVERVIEW AND PLAN OF OPERATION
We were previously a dietary supplement company specializing in the development, marketing and distribution of all natural, proprietary, dietary supplements under the names Trim For Life3 Appetite Control and Trim For Life3 Energy Formula.
In our original business plan, we outlined a marketing strategy to compete more effectively in the dietary supplement marketplace. However, due to a lack of available financing, we were unable to implement the marketing strategy or invest in product expansion. We are no longer pursuing this business. As a result, we began to explore other viable options that may provide the potential to generate a positive cash flow to accommodate the costs of being a public company. With volatile economic conditions and unknown opportunities, we are unable to adequately determine if there are indeed, business opportunities that would lend to the Company acquiring additional capital or having the available resources to construct such a deal.
11
Our common stock is traded in the over-the-counter market under the symbol LIPN. Since January 20, 2009, it has been listed on the OTC Bulletin Board. As a public company with the potential for shares to trade on the open market, we believe our company may be in a better position to raise additional capital to meet our operating costs. However, we cannot claim nor guarantee that by having Company stock publicly quoted that it will provide the opportunity to raise additional capital.
Our current operating costs are minimal due to limited business activities, but we do incur an expense in ongoing legal and professional services to meet our SEC obligations as a publicly held company. The Company may continue to meet these expenses by opting to raise additional capital through sales of our common stock, loans from our board of directors and affiliates, and/or other transactions to meet these obligations.
Recent Developments
On September 7, 2010, we entered into a Share Exchange Agreement (the Share Exchange Agreement) with Conqueror Group Limited, a Hong Kong corporation (Conqueror) and Acumen Charm Ltd., a British Virgin Islands corporation (the Conqueror Shareholder). Pursuant to the Agreement, at the closing of the transaction contemplated in the Share Exchange Agreement (the Transaction), the Company will acquire 100% of the issued and outstanding capital stock of Conqueror from the Conqueror Shareholder, making Conqueror a wholly-owned subsidiary of the Company. There was no prior relationship between the Company and any of its affiliates and the Conqueror Shareholder and any of its affiliates.
Conqueror owns 100% of the equity interest of Shenyang Kai Xin, a wholly-owned foreign enterprise incorporated in the Peoples Republic of China (PRC), which entity has entered into contractual arrangements with Liaoning New Land Food & Beverage Co., Limited (NLFB) and Liaoning New Land Fast Frozen Food Co. Limited (NLFF), each a company incorporated in the PRC, which arrangements give Conqueror effective control of the business of NLFB and NLFF. NLFB is principally engaged in the processing and distribution of raspberry and blueberry drinks, wines and other related products in China, and NLFF is principally engaged in the cultivation, processing and distribution of fresh and frozen raspberries in the domestic market in China and internationally.
In consideration for the purchase of the Conqueror Shareholders interest in Conqueror, the Company will issue to designees of the Conqueror Shareholder a total of 23,905,000 newly issued shares of the Companys common stock.
The closing of the Transaction is conditioned upon, among other things, satisfactory due diligence investigations by the parties, the cancellation of a total of 13,787,800 shares of the Companys common stock by certain shareholders of the Company, the ability of certain designees of Conqueror to purchase a total of 4,010,000 shares of the Companys common stock from non-affiliated shareholders of the Company in unrelated transactions, the accuracy at closing of the representations made by the parties in the Share Exchange Agreement, and the obtaining of necessary consents.
The First Amendment to the Share Exchange Agreement (the First Amendment) was entered into on November 17, 2010 by the Company with Conqueror and the Conqueror Shareholder. The First Amendment amends the terms of the Share Exchange Agreement in which 1,004,900 shares shall be redeemed by the Company contemporaneously with the execution of the First Amendment at an aggregate redemption price of $55,270 (the Group B Redemption Price) and 12,782,900 shares shall be redeemed by the Company at or before the closing at an aggregate redemption price of $49,731 (the Group C Redemption Price) pursuant to mutually acceptable and duly executed redemption agreements.
Contemporaneously with the execution of the First Amendment, Conqueror loaned the Company the principal amount of $55,270 in exchange for which the Company delivered a promissory note to Conqueror which proceeds were used to pay the Group B Redemption Price. The First Amendment further provides that at or before the closing, Conqueror shall loan the Company the principal amount of
12
$49,731 which shall be paid from the funds remaining in escrow (the "Remaining Escrow Funds") pursuant to the Escrow Agreement dated as of August 13, 2010, as amended on August 30, 2010, by and among Conqueror, the Company and Cyruli Shanks Hart & Zizmor LLP, in exchange for which the Company shall deliver a promissory note to Conqueror which proceeds shall be used to pay the Group C Redemption Price.
The First Amendment also provides that in the event that the closing does not occur for any reason on or before January 31, 2011, then, among other things, the Remaining Escrow Funds shall be paid to the Company and used to promptly redeem 12,782,900 shares as provided therein at the Group C Redemption Price, and the then officers and directors of the Company shall resign with immediate effect and appoint such persons as designated by Conqueror as officers and directors.
The Closing was to transpire on or before January 31, 2011 but, as of the date hereof, has not occurred. As a result, as of May 11, 2011, and in accordance with the terms of the First Amendment, the Remaining Escrow Funds were paid to the Company and were used to redeem 12,782,900 shares at the Group C Redemption Price and the Company delivered a promissory note to Conqueror in the principal amount of $49,731. In addition, on May 11, 2011, Michael M. Salerno, the Company's sole officer and director, resigned as an officer and director of the Company, and appointed Chu Zhanjun and Li Gang as directors, and Chu Zhanjun as President, Chief Executive Officer and Principal Financial Officer of the Company, each a designee of Conqueror.
As a result, a change in control has occurred, due to the resignation of Mr. Salerno as sole officer and director, appointment of Mr. Zhanjun as President, Chief Executive Officer and Principal Financial Officer of the Company, and appointment of Mr. Zhanjun and Mr. Gang as directors which appointments as directors shall be effective immediately after the expiration of the 10 day period following the date after which this Information Statement is filed with the SEC and transmitted to you.
As of the date hereof, we do not expect that the transaction contemplated by the Share Exchange Agreement will be completed at any time in future.
RESULTS OF OPERATIONS
Three months ended March 31, 2011 compared to three months ended March 31, 2010
Revenue: Revenue was $0 for the three months ended March 31, 2011 compared to $118 for the three months ended March 31, 2010, a decrease of $118. This decrease is a result of limited marketing activities and expired inventory.
Gross Profit: Gross profit was $0 for the three months ended March 31, 2011 compared to $48 for the three months ended March 31, 2010, a decrease of $48. This decrease in gross profit is due to the sales decrease and inventory impairment.
Selling, General and Administrative Expenses: Selling, general and administrative expenses were $21,626 for the three months ended March 31, 2011 compared to $9,732 for the three months ended March 31, 2010, an increase of $11,894 due professional fees related to the share exchange agreement.
Other Income (Expense): Other income (expense) was ($688) for the three months ended March 31, 2011 compared to $0 for the three months ended March 31, 2010 due to 5% accrued interest on a $55,000 loan payable to Conqueror Group Limited.
IMPACT of INFLATION
Inflation has not had a material effect on our results of operations.
13
LIQUIDITY and CAPITAL RESOURCES
Net cash used in operating activities was ($18,318) for the three months ended March 31, 2011, compared to net cash used by operating activities ($1,306) for the three months ended March 31, 2010. This increase in cash is primarily the result of payments of accounts payable, accrued expenses and professional fees.
As of March 31, 2011, the Company had $499 in cash. It is meeting its working capital needs by relying upon the proceeds from stock issuances and loans. As of March 31, 2011, there is a promissory note of $55,000 outstanding.
Obligations are being met on a month-to-month basis as cash becomes available. There can be no assurances that the Company's present flow of cash will be sufficient to meet current and future obligations. The Company has incurred losses since its inception, and continues to require additional capital to fund operations and meet SEC requirements of being a publicly held company. As such, the Company's ability to pay its already incurred obligations is mostly dependent on the Company achieving its revenue goals or raising additional capital in the form of equity or debt.
OFF-BALANCE SHEET ARRANGEMENTS
We do not have any off balance sheet arrangements that are reasonably likely to have a current or future effect on our financial condition, revenues, results of operations, liquidity or capital resources.
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.
Item 4. Controls and Procedures.
(a) Evaluation of disclosure controls and procedures
The Company's management, with the participation of the Company's Chief Executive Officer, has evaluated the effectiveness of the Company's disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act")) as of the end of the period covered by this report. Based on such evaluation, the Company's Chief Executive Officer has concluded that, as of the end of such period, the Company's disclosure controls and procedures are not effective.
The matters involving internal controls and procedures that our management considered to be material weaknesses under the standards of the Public Company Accounting Oversight Board were: (1) inadequate segregation of duties consistent with control objectives; and (2) ineffective controls over period end financial disclosure and reporting processes. The aforementioned material weaknesses were identified by our Chief Executive Officer in connection with the review of our financial statements as of March 31, 2011.
Management believes that the material weaknesses set forth in items (1) and (2) above did not have an effect on our financial results. At this time, the Company does not have an audit committee and relies on its Board of Directors and executive management to monitor internal controls and procedures to ensure the Company is meeting its SEC obligations
14
There have not been any changes in the Company's internal control over financial reporting during the fiscal quarter to which this report relates that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.
(c) Inherent Limitations on Effectiveness of Controls
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. All internal control systems, no matter how well designed, have inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. Because of the inherent limitations of internal control, there is a risk that material misstatements may not be prevented or detected on a timely basis by internal control over financial reporting. However, these inherent limitations are known features of the financial reporting process. Therefore, it is possible to design into the process safeguards to reduce, though not eliminate, this risk.
PART II-OTHER INFORMATION
Item 1. Legal Proceedings
There are no material pending legal proceedings to which the Company is a party or to which any of its property is subject.
Item 1A. Risk Factors
We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
None.
Item 3. Defaults Upon Senior Securities
None.
Item 4. [Removed and Reserved]
Item 5. Other Information.
None.
Item 6. Exhibits.
31.1 | Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (Rules 13a-14 and 15d-14 of the Exchange Act) |
|
31.2 | Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (Rules 13a-14 and 15d-14 of the Exchange Act) |
|
32.1 Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350) |
15
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
LIFE NUTRITION PRODUCTS, INC. | |||
(Registrant) | |||
Dated: | May 23, 2011 | By: | /s/ Chu Zhanjun |
Chu Zhanjun | |||
Chief Executive Officer | |||
Dated: | May 23, 2011 | By: | /s/ Chu Zhanjun |
Chu Zhanjun | |||
Principal Financial Officer |
16
Exhibit 31.1
CERTIFICATION
I, Chu Zhanjun, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Life Nutrition Products, Inc.; |
2. Based on my knowledge, this report does not contain any untrue statements of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonable likely to materially affect, the registrant's internal control over financial reporting; and
5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
Dated: May 23, 2011 | By: | /s/ Chu Zhanjun |
Chu Zhanjun,
| ||
Exhibit 31.2
CERTIFICATION
I, Chu Zhanjun, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Life Nutrition Products, Inc.; |
2. Based on my knowledge, this report does not contain any untrue statements of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonable likely to materially affect, the registrant's internal control over financial reporting; and
5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
Dated: May 23, 2011 | By: | /s/ Chu Zhanjun |
Chu Zhanjun
| ||
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Life Nutrition Products, Inc. (the "Company") on Form 10-Q for the period ended March 31, 2011, as filed with the Securities and Exchange Commission (the "Report"), the undersigned certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of the undersigned's knowledge, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial
condition and results of operations of the Company.
Dated: May 23, 2011 | By: | /s/ Chu Zhanjun |
Chu Zhanjun,
| ||
Dated: May 23, 2011 | By: | /s/ Chu Zhanjun |
Chu Zhanjun Principal Financial Officer |